Mouse study finds skull immune hubs that fight brain cancer
Under the scalp of a mouse with glioblastoma, a gel carrying three immune-boosting proteins triggered a response in a place scientists had not recognized before: the skull's bone marrow. Researchers at Washington University School of Medicine in St. Louis found lymph node-like immune hubs there, and showed that they can respond to brain cancer before lymph nodes farther away receive the signal.
The finding challenges the once widely accepted picture of the brain as largely cut off from immune defenses. Jonathan Kipnis's team had already identified lymphatic vessels in the dura, the membrane surrounding the brain, and tiny channels connecting the skull, dura and brain. In the new mouse study, proteins moving out of the brain through those channels led researchers to structures normally associated with lymph nodes.
Those structures are not passive storage sites. They serve as training grounds where T follicular helper cells—immune cells that assist B cells—help produce large amounts of antibodies. When the researchers disrupted the skull hubs with a drug, glioblastoma tumors grew faster and the mice survived for less time. The result suggests that the brain uses this nearby immune post as an early line of defense.
The team then targeted the same location with a gel applied directly under the scalp. The resulting immune response began in the skull marrow and later appeared in nearby lymph nodes outside the skull. Treated mice showed better tumor rejection and lived longer than control mice. The study also found evidence of similar immune cells in human skull bone marrow, though it did not show that the gel works in people.
So what changes, concretely? The skull could become a route for future treatments aimed at immune responses near the brain, potentially avoiding some effects on the rest of the body. For now, the evidence is limited to mice for the cancer treatment, while the human finding is evidence of similar cells—not a proven human immune organ or therapy.
Kommentare
Der Thread wird geladen…
Melden Sie sich an, um einen Kommentar zu schreiben. Anmelden